Clinical Trial Update: Luspatercept Plus CsA vs CsA for the Treatment of Newly Diagnosed Non-Transfusion-Dependent NSAA [Phase 4]

View source ↗

Summary

This clinical trial update describes a Phase 4 study comparing luspatercept plus cyclosporine vs cyclosporine alone for newly diagnosed non-transfusion-dependen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia

Drugs mentioned

• CYCLOSPORINE (cyclosporine)
• REBLOZYL (LUSPATERCEPT)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Aplastic Anemia | Phase 4 | Status: NOT_YET_RECRUITING